Gilgamesh Pharmaceuticals
Clinical trials sponsored by Gilgamesh Pharmaceuticals, explained in plain language.
-
New depression drug GM-2505 enters Mid-Stage trial
Symptom relief CompletedThis study tests an experimental drug called GM-2505 in people with major depressive disorder. Participants receive two doses of the drug two weeks apart. The study has three parts: one for people not on antidepressants, one for those partially responding to current treatment, an…
Phase 2 • Sponsor: Gilgamesh Pharmaceuticals • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
New depression pill shows promise in early trial
Symptom relief CompletedThis study tested an experimental oral drug, GM-1020, in 46 adults with major depressive disorder. The goal was to check safety and see if it can quickly improve mood. Researchers measured side effects and depression scores over 24 hours.
Phase 2 • Sponsor: Gilgamesh Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC